Beranda › Artritis Reumatoid › New York
Uji klinis Artritis Reumatoid di New York
15 studi untuk Artritis Reumatoid mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
RA-PRO PRAGMATIC TRIAL
- New York University, New York
- Hospital for Special Surgery, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- dan 1 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Local Institution - 0081, New York
- Local Institution - 0079, New York
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07412704A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Northwell Health Physician Partners Rheumatology At Great Neck /ID# 275621, Great Neck
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Equity Medical, The Bronx
- Equity Medical, The Bronx
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07137598Exactech Shoulder Post Market Clinical Follow-up Study
- Hospital for Joint Diseases - NYU Langone Health, New York
- Lenox Health Greenwich Village, New York
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05603728A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06570798A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Stony Brook
- Nkarta Investigational Site, Syracuse
Menerima pesertaFase 1/2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06733935A Study of AZD0120 in Autoimmune Diseases
- Research Site, New York
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07295847Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07138898Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)
- University of Rochester, Rochester
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT05197530Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
- Hospital for Special Surgery, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT05782335Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
- Weill Cornell Medical College, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT07222696Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
- St. Lawrence Health, Potsdam
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jun 2025 · NCT07034196ConsideRAte Study - Splenic Stimulation for RA
- NYU Langone, Brooklyn
Menerima peserta
Usia 22 hingga 75 · Semua jenis kelamin · Diperbarui 22 Mei 2024 · NCT05003310Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.